Alterity Therapeutics Limited (ATH.AX)
Develops experimental drugs to treat Parkinson's disease and multiple system atrophy
0.51-0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-27.1%
The outlook
Alterity Therapeutics is trading near the lower end of its 52-week range at 0.51. Analyst price targets average roughly 347% above the current level, though coverage appears limited. The stock shows mixed momentum against its moving averages, sitting in neutral territory overall.
What’s behind the score
Price trendMixed vs its moving averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +347% vs current price
Analyst price target
~12-month · 2 analysts2.28average target+347.1% vs now
Now 0.51
Low 0.95High 3.61
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$110.9M
52-wk high
0.79
52-wk low
0.35
50-day avg
0.54
200-day avg
0.47
Trailing P/E
—